Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes Article Swipe
Nicholas Wald
,
Aroon D. Hingorani
,
Stephen H Vale
,
Jonathan P. Bestwick
,
Joan K. Morris
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1177/09691413241235488
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1177/09691413241235488
Objective To compare the NHS Health Check Programme with the Polypill Prevention Programme in the primary prevention of heart attacks and strokes. Design Use of published data and methodology to produce flow charts of the two programmes to determine screening performance and heart attacks and strokes prevented. Setting The UK population. Intervention The NHS Health Check Programme using a QRISK score on people aged 40–74 to select those eligible for a statin is compared with the Polypill Prevention Programme in people aged 50 or more to select people for a combination of a statin and three low-dose blood pressure lowering agents. In both programmes, people had no history of heart attack or stroke. Main outcome measures In 1000 people, the number of heart attacks and strokes prevented in the two programmes. Results In the hypothetical perfect situation with 100% uptake and adherence to the screening protocol, in every 1000 persons, the NHS Health Check would prevent 287 cases of a heart attack or stroke in individuals who would gain on average about 4 years of life without a heart attack or stroke amounting to 1148 years in total, the precise gain depending on the extent of treatment for those with raised blood pressure, and 136 would be prescribed statins with no benefit. The corresponding figures for the Polypill Prevention Programme are 316 individuals who would, on average, gain 8 years of life without a heart attack or stroke, amounting to 2528 years in total, and 260 prescribed the polypill with no benefit. Based on published estimates of uptake and adherence in the NHS Health Check Programme, in practice only 24 cases per 1000 are currently benefitting instead of 287, amounting to 96 years gained without a heart attack or stroke. Conclusions The Polypill Prevention Programme is by design simpler with the potential of preventing many more heart attacks and strokes than the NHS Health Check Programme.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1177/09691413241235488
- https://journals.sagepub.com/doi/pdf/10.1177/09691413241235488
- OA Status
- hybrid
- Cited By
- 7
- References
- 32
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392854764
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392854764Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/09691413241235488Digital Object Identifier
- Title
-
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-03-15Full publication date if available
- Authors
-
Nicholas Wald, Aroon D. Hingorani, Stephen H Vale, Jonathan P. Bestwick, Joan K. MorrisList of authors in order
- Landing page
-
https://doi.org/10.1177/09691413241235488Publisher landing page
- PDF URL
-
https://journals.sagepub.com/doi/pdf/10.1177/09691413241235488Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://journals.sagepub.com/doi/pdf/10.1177/09691413241235488Direct OA link when available
- Concepts
-
Polypill, Medicine, Primary prevention, Cancer prevention, Secondary prevention, Family medicine, Alternative medicine, Internal medicine, Cancer, Pathology, DiseaseTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
7Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4, 2024: 3Per-year citation counts (last 5 years)
- References (count)
-
32Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392854764 |
|---|---|
| doi | https://doi.org/10.1177/09691413241235488 |
| ids.doi | https://doi.org/10.1177/09691413241235488 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38486473 |
| ids.openalex | https://openalex.org/W4392854764 |
| fwci | 9.42036292 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008875 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Middle Aged |
| mesh[2].qualifier_ui | Q000517 |
| mesh[2].descriptor_ui | D020521 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | prevention & control |
| mesh[2].descriptor_name | Stroke |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000368 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Aged |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006113 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | United Kingdom |
| mesh[5].qualifier_ui | Q000517 |
| mesh[5].descriptor_ui | D009203 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | prevention & control |
| mesh[5].descriptor_name | Myocardial Infarction |
| mesh[6].qualifier_ui | Q000175 |
| mesh[6].descriptor_ui | D009203 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | diagnosis |
| mesh[6].descriptor_name | Myocardial Infarction |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000328 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Adult |
| mesh[8].qualifier_ui | Q000379 |
| mesh[8].descriptor_ui | D008403 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | methods |
| mesh[8].descriptor_name | Mass Screening |
| mesh[9].qualifier_ui | Q000379 |
| mesh[9].descriptor_ui | D011322 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | methods |
| mesh[9].descriptor_name | Primary Prevention |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D008297 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Male |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D005260 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Female |
| mesh[12].qualifier_ui | Q000008 |
| mesh[12].descriptor_ui | D019161 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | administration & dosage |
| mesh[12].descriptor_name | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D019161 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D013222 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | State Medicine |
| mesh[15].qualifier_ui | Q000008 |
| mesh[15].descriptor_ui | D000959 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | administration & dosage |
| mesh[15].descriptor_name | Antihypertensive Agents |
| mesh[16].qualifier_ui | Q000627 |
| mesh[16].descriptor_ui | D000959 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | therapeutic use |
| mesh[16].descriptor_name | Antihypertensive Agents |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D008875 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Middle Aged |
| mesh[19].qualifier_ui | Q000517 |
| mesh[19].descriptor_ui | D020521 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | prevention & control |
| mesh[19].descriptor_name | Stroke |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D000368 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Aged |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006113 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | United Kingdom |
| mesh[22].qualifier_ui | Q000517 |
| mesh[22].descriptor_ui | D009203 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | prevention & control |
| mesh[22].descriptor_name | Myocardial Infarction |
| mesh[23].qualifier_ui | Q000175 |
| mesh[23].descriptor_ui | D009203 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | diagnosis |
| mesh[23].descriptor_name | Myocardial Infarction |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000328 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Adult |
| mesh[25].qualifier_ui | Q000379 |
| mesh[25].descriptor_ui | D008403 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | methods |
| mesh[25].descriptor_name | Mass Screening |
| mesh[26].qualifier_ui | Q000379 |
| mesh[26].descriptor_ui | D011322 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | methods |
| mesh[26].descriptor_name | Primary Prevention |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008297 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Male |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D005260 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Female |
| mesh[29].qualifier_ui | Q000008 |
| mesh[29].descriptor_ui | D019161 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | administration & dosage |
| mesh[29].descriptor_name | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| mesh[30].qualifier_ui | Q000627 |
| mesh[30].descriptor_ui | D019161 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | therapeutic use |
| mesh[30].descriptor_name | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D013222 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | State Medicine |
| mesh[32].qualifier_ui | Q000008 |
| mesh[32].descriptor_ui | D000959 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | administration & dosage |
| mesh[32].descriptor_name | Antihypertensive Agents |
| mesh[33].qualifier_ui | Q000627 |
| mesh[33].descriptor_ui | D000959 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | therapeutic use |
| mesh[33].descriptor_name | Antihypertensive Agents |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D006801 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Humans |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D008875 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Middle Aged |
| mesh[36].qualifier_ui | Q000517 |
| mesh[36].descriptor_ui | D020521 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | prevention & control |
| mesh[36].descriptor_name | Stroke |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D000368 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Aged |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D006113 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | United Kingdom |
| mesh[39].qualifier_ui | Q000517 |
| mesh[39].descriptor_ui | D009203 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | prevention & control |
| mesh[39].descriptor_name | Myocardial Infarction |
| mesh[40].qualifier_ui | Q000175 |
| mesh[40].descriptor_ui | D009203 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | diagnosis |
| mesh[40].descriptor_name | Myocardial Infarction |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D000328 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Adult |
| mesh[42].qualifier_ui | Q000379 |
| mesh[42].descriptor_ui | D008403 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | methods |
| mesh[42].descriptor_name | Mass Screening |
| mesh[43].qualifier_ui | Q000379 |
| mesh[43].descriptor_ui | D011322 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | methods |
| mesh[43].descriptor_name | Primary Prevention |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D008297 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Male |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D005260 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Female |
| mesh[46].qualifier_ui | Q000008 |
| mesh[46].descriptor_ui | D019161 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | administration & dosage |
| mesh[46].descriptor_name | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| mesh[47].qualifier_ui | Q000627 |
| mesh[47].descriptor_ui | D019161 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | therapeutic use |
| mesh[47].descriptor_name | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D013222 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | State Medicine |
| mesh[49].qualifier_ui | Q000008 |
| mesh[49].descriptor_ui | D000959 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | administration & dosage |
| mesh[49].descriptor_name | Antihypertensive Agents |
| type | article |
| title | Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes |
| biblio.issue | 2 |
| biblio.volume | 31 |
| biblio.last_page | 65 |
| biblio.first_page | 59 |
| topics[0].id | https://openalex.org/T14212 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2739 |
| topics[0].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[0].display_name | Health Promotion and Cardiovascular Prevention |
| topics[1].id | https://openalex.org/T12246 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9945999979972839 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Chronic Disease Management Strategies |
| topics[2].id | https://openalex.org/T11083 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9872999787330627 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2705 |
| topics[2].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[2].display_name | Cardiac Health and Mental Health |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777758740 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9607254862785339 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2103071 |
| concepts[0].display_name | Polypill |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.9289149045944214 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2993857929 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7749330401420593 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1773974 |
| concepts[2].display_name | Primary prevention |
| concepts[3].id | https://openalex.org/C2780234812 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5459299683570862 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1787013 |
| concepts[3].display_name | Cancer prevention |
| concepts[4].id | https://openalex.org/C3019417119 |
| concepts[4].level | 2 |
| concepts[4].score | 0.48467591404914856 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1773974 |
| concepts[4].display_name | Secondary prevention |
| concepts[5].id | https://openalex.org/C512399662 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4572271406650543 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[5].display_name | Family medicine |
| concepts[6].id | https://openalex.org/C204787440 |
| concepts[6].level | 2 |
| concepts[6].score | 0.41995713114738464 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[6].display_name | Alternative medicine |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.14901411533355713 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.12177512049674988 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| concepts[9].id | https://openalex.org/C142724271 |
| concepts[9].level | 1 |
| concepts[9].score | 0.08558693528175354 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[9].display_name | Pathology |
| concepts[10].id | https://openalex.org/C2779134260 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[10].display_name | Disease |
| keywords[0].id | https://openalex.org/keywords/polypill |
| keywords[0].score | 0.9607254862785339 |
| keywords[0].display_name | Polypill |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.9289149045944214 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/primary-prevention |
| keywords[2].score | 0.7749330401420593 |
| keywords[2].display_name | Primary prevention |
| keywords[3].id | https://openalex.org/keywords/cancer-prevention |
| keywords[3].score | 0.5459299683570862 |
| keywords[3].display_name | Cancer prevention |
| keywords[4].id | https://openalex.org/keywords/secondary-prevention |
| keywords[4].score | 0.48467591404914856 |
| keywords[4].display_name | Secondary prevention |
| keywords[5].id | https://openalex.org/keywords/family-medicine |
| keywords[5].score | 0.4572271406650543 |
| keywords[5].display_name | Family medicine |
| keywords[6].id | https://openalex.org/keywords/alternative-medicine |
| keywords[6].score | 0.41995713114738464 |
| keywords[6].display_name | Alternative medicine |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.14901411533355713 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.12177512049674988 |
| keywords[8].display_name | Cancer |
| keywords[9].id | https://openalex.org/keywords/pathology |
| keywords[9].score | 0.08558693528175354 |
| keywords[9].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1177/09691413241235488 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S46527232 |
| locations[0].source.issn | 0969-1413, 1475-5793 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0969-1413 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Medical Screening |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_lineage_names | SAGE Publishing |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/09691413241235488 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Medical Screening |
| locations[0].landing_page_url | https://doi.org/10.1177/09691413241235488 |
| locations[1].id | pmid:38486473 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of medical screening |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38486473 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11083722 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Med Screen |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11083722 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5048397189 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1676-5908 |
| authorships[0].author.display_name | Nicholas Wald |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I165862685 |
| authorships[0].affiliations[0].raw_affiliation_string | Population Health Research Institute, St Georges University of London, London, UK |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I45129253 |
| authorships[0].affiliations[1].raw_affiliation_string | Institute of Health Informatics, University College London, London, UK |
| authorships[0].institutions[0].id | https://openalex.org/I165862685 |
| authorships[0].institutions[0].ror | https://ror.org/040f08y74 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I165862685 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | St George's, University of London |
| authorships[0].institutions[1].id | https://openalex.org/I45129253 |
| authorships[0].institutions[1].ror | https://ror.org/02jx3x895 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I124357947, https://openalex.org/I45129253 |
| authorships[0].institutions[1].country_code | GB |
| authorships[0].institutions[1].display_name | University College London |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Nicholas J Wald |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Institute of Health Informatics, University College London, London, UK, Population Health Research Institute, St Georges University of London, London, UK |
| authorships[1].author.id | https://openalex.org/A5081842404 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8365-0081 |
| authorships[1].author.display_name | Aroon D. Hingorani |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I45129253 |
| authorships[1].affiliations[0].raw_affiliation_string | Institute of Health Informatics, University College London, London, UK |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I45129253 |
| authorships[1].affiliations[1].raw_affiliation_string | Institute of Cardiovascular Science, University College London, London, UK |
| authorships[1].institutions[0].id | https://openalex.org/I45129253 |
| authorships[1].institutions[0].ror | https://ror.org/02jx3x895 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I45129253 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | University College London |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Aroon D Hingorani |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Institute of Cardiovascular Science, University College London, London, UK, Institute of Health Informatics, University College London, London, UK |
| authorships[2].author.id | https://openalex.org/A5006715734 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6000-3746 |
| authorships[2].author.display_name | Stephen H Vale |
| authorships[2].affiliations[0].raw_affiliation_string | Logical Medical Systems, London, UK |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Stephen H Vale |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Logical Medical Systems, London, UK |
| authorships[3].author.id | https://openalex.org/A5056651699 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-3088-8616 |
| authorships[3].author.display_name | Jonathan P. Bestwick |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I166337079 |
| authorships[3].affiliations[0].raw_affiliation_string | Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK |
| authorships[3].institutions[0].id | https://openalex.org/I166337079 |
| authorships[3].institutions[0].ror | https://ror.org/026zzn846 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I166337079 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | Queen Mary University of London |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jonathan P Bestwick |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK |
| authorships[4].author.id | https://openalex.org/A5026810074 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7164-612X |
| authorships[4].author.display_name | Joan K. Morris |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I165862685 |
| authorships[4].affiliations[0].raw_affiliation_string | Population Health Research Institute, St Georges University of London, London, UK |
| authorships[4].institutions[0].id | https://openalex.org/I165862685 |
| authorships[4].institutions[0].ror | https://ror.org/040f08y74 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I165862685 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | St George's, University of London |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Joan Morris |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Population Health Research Institute, St Georges University of London, London, UK |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.sagepub.com/doi/pdf/10.1177/09691413241235488 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T14212 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2739 |
| primary_topic.subfield.display_name | Public Health, Environmental and Occupational Health |
| primary_topic.display_name | Health Promotion and Cardiovascular Prevention |
| related_works | https://openalex.org/W4324387507, https://openalex.org/W1853344227, https://openalex.org/W2067841861, https://openalex.org/W307376781, https://openalex.org/W3027694689, https://openalex.org/W4323040378, https://openalex.org/W4307861480, https://openalex.org/W4213032494, https://openalex.org/W4250456125, https://openalex.org/W1607738240 |
| cited_by_count | 7 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1177/09691413241235488 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S46527232 |
| best_oa_location.source.issn | 0969-1413, 1475-5793 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0969-1413 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Medical Screening |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_lineage_names | SAGE Publishing |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/09691413241235488 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Medical Screening |
| best_oa_location.landing_page_url | https://doi.org/10.1177/09691413241235488 |
| primary_location.id | doi:10.1177/09691413241235488 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S46527232 |
| primary_location.source.issn | 0969-1413, 1475-5793 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0969-1413 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Medical Screening |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_lineage_names | SAGE Publishing |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/09691413241235488 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Medical Screening |
| primary_location.landing_page_url | https://doi.org/10.1177/09691413241235488 |
| publication_date | 2024-03-15 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2031968478, https://openalex.org/W2055838663, https://openalex.org/W2163207768, https://openalex.org/W2110171695, https://openalex.org/W2160547085, https://openalex.org/W2969273075, https://openalex.org/W2973824785, https://openalex.org/W3101533148, https://openalex.org/W4293176633, https://openalex.org/W2592193040, https://openalex.org/W1993856759, https://openalex.org/W4230304476, https://openalex.org/W3097431637, https://openalex.org/W2340711960, https://openalex.org/W2137899853, https://openalex.org/W2072788163, https://openalex.org/W1544587904, https://openalex.org/W75245760, https://openalex.org/W3157857666, https://openalex.org/W2054796764, https://openalex.org/W2107993459, https://openalex.org/W1970548926, https://openalex.org/W2519634482, https://openalex.org/W1776477763, https://openalex.org/W1995987981, https://openalex.org/W2116767991, https://openalex.org/W2288332644, https://openalex.org/W4385719147, https://openalex.org/W3126343500, https://openalex.org/W2051620560, https://openalex.org/W2766051043, https://openalex.org/W4317884047 |
| referenced_works_count | 32 |
| abstract_inverted_index.4 | 172 |
| abstract_inverted_index.8 | 228 |
| abstract_inverted_index.a | 58, 70, 89, 92, 159, 177, 233, 285 |
| abstract_inverted_index.24 | 269 |
| abstract_inverted_index.50 | 82 |
| abstract_inverted_index.96 | 281 |
| abstract_inverted_index.In | 101, 116, 132 |
| abstract_inverted_index.To | 1 |
| abstract_inverted_index.UK | 49 |
| abstract_inverted_index.be | 206 |
| abstract_inverted_index.by | 296 |
| abstract_inverted_index.in | 13, 79, 127, 146, 164, 186, 242, 260, 266 |
| abstract_inverted_index.is | 72, 295 |
| abstract_inverted_index.no | 106, 210, 250 |
| abstract_inverted_index.of | 17, 24, 33, 91, 108, 121, 158, 174, 195, 230, 256, 277, 302 |
| abstract_inverted_index.on | 61, 169, 192, 225, 253 |
| abstract_inverted_index.or | 83, 111, 162, 180, 236, 288 |
| abstract_inverted_index.to | 29, 37, 65, 85, 142, 183, 239, 280 |
| abstract_inverted_index.136 | 204 |
| abstract_inverted_index.260 | 245 |
| abstract_inverted_index.287 | 156 |
| abstract_inverted_index.316 | 221 |
| abstract_inverted_index.NHS | 4, 53, 151, 262, 312 |
| abstract_inverted_index.The | 48, 52, 212, 291 |
| abstract_inverted_index.Use | 23 |
| abstract_inverted_index.and | 20, 27, 41, 44, 94, 124, 140, 203, 244, 258, 308 |
| abstract_inverted_index.are | 220, 273 |
| abstract_inverted_index.for | 69, 88, 197, 215 |
| abstract_inverted_index.had | 105 |
| abstract_inverted_index.per | 271 |
| abstract_inverted_index.the | 3, 9, 14, 34, 75, 119, 128, 133, 143, 150, 188, 193, 216, 247, 261, 300, 311 |
| abstract_inverted_index.two | 35, 129 |
| abstract_inverted_index.who | 166, 223 |
| abstract_inverted_index.100% | 138 |
| abstract_inverted_index.1000 | 117, 148, 272 |
| abstract_inverted_index.1148 | 184 |
| abstract_inverted_index.2528 | 240 |
| abstract_inverted_index.287, | 278 |
| abstract_inverted_index.Main | 113 |
| abstract_inverted_index.aged | 63, 81 |
| abstract_inverted_index.both | 102 |
| abstract_inverted_index.data | 26 |
| abstract_inverted_index.flow | 31 |
| abstract_inverted_index.gain | 168, 190, 227 |
| abstract_inverted_index.life | 175, 231 |
| abstract_inverted_index.many | 304 |
| abstract_inverted_index.more | 84, 305 |
| abstract_inverted_index.only | 268 |
| abstract_inverted_index.than | 310 |
| abstract_inverted_index.with | 8, 74, 137, 199, 209, 249, 299 |
| abstract_inverted_index.Based | 252 |
| abstract_inverted_index.Check | 6, 55, 153, 264, 314 |
| abstract_inverted_index.QRISK | 59 |
| abstract_inverted_index.about | 171 |
| abstract_inverted_index.blood | 97, 201 |
| abstract_inverted_index.cases | 157, 270 |
| abstract_inverted_index.every | 147 |
| abstract_inverted_index.heart | 18, 42, 109, 122, 160, 178, 234, 286, 306 |
| abstract_inverted_index.score | 60 |
| abstract_inverted_index.those | 67, 198 |
| abstract_inverted_index.three | 95 |
| abstract_inverted_index.using | 57 |
| abstract_inverted_index.would | 154, 167, 205 |
| abstract_inverted_index.years | 173, 185, 229, 241, 282 |
| abstract_inverted_index.Design | 22 |
| abstract_inverted_index.Health | 5, 54, 152, 263, 313 |
| abstract_inverted_index.attack | 110, 161, 179, 235, 287 |
| abstract_inverted_index.charts | 32 |
| abstract_inverted_index.design | 297 |
| abstract_inverted_index.extent | 194 |
| abstract_inverted_index.gained | 283 |
| abstract_inverted_index.number | 120 |
| abstract_inverted_index.people | 62, 80, 87, 104 |
| abstract_inverted_index.raised | 200 |
| abstract_inverted_index.select | 66, 86 |
| abstract_inverted_index.statin | 71, 93 |
| abstract_inverted_index.stroke | 163, 181 |
| abstract_inverted_index.total, | 187, 243 |
| abstract_inverted_index.uptake | 139, 257 |
| abstract_inverted_index.would, | 224 |
| abstract_inverted_index.40–74 | 64 |
| abstract_inverted_index.Results | 131 |
| abstract_inverted_index.Setting | 47 |
| abstract_inverted_index.agents. | 100 |
| abstract_inverted_index.attacks | 19, 43, 123, 307 |
| abstract_inverted_index.average | 170 |
| abstract_inverted_index.compare | 2 |
| abstract_inverted_index.figures | 214 |
| abstract_inverted_index.history | 107 |
| abstract_inverted_index.instead | 276 |
| abstract_inverted_index.outcome | 114 |
| abstract_inverted_index.people, | 118 |
| abstract_inverted_index.perfect | 135 |
| abstract_inverted_index.precise | 189 |
| abstract_inverted_index.prevent | 155 |
| abstract_inverted_index.primary | 15 |
| abstract_inverted_index.produce | 30 |
| abstract_inverted_index.simpler | 298 |
| abstract_inverted_index.statins | 208 |
| abstract_inverted_index.stroke, | 237 |
| abstract_inverted_index.stroke. | 112, 289 |
| abstract_inverted_index.strokes | 45, 125, 309 |
| abstract_inverted_index.without | 176, 232, 284 |
| abstract_inverted_index.Polypill | 10, 76, 217, 292 |
| abstract_inverted_index.average, | 226 |
| abstract_inverted_index.benefit. | 211, 251 |
| abstract_inverted_index.compared | 73 |
| abstract_inverted_index.eligible | 68 |
| abstract_inverted_index.low-dose | 96 |
| abstract_inverted_index.lowering | 99 |
| abstract_inverted_index.measures | 115 |
| abstract_inverted_index.persons, | 149 |
| abstract_inverted_index.polypill | 248 |
| abstract_inverted_index.practice | 267 |
| abstract_inverted_index.pressure | 98 |
| abstract_inverted_index.strokes. | 21 |
| abstract_inverted_index.Objective | 0 |
| abstract_inverted_index.Programme | 7, 12, 56, 78, 219, 294 |
| abstract_inverted_index.adherence | 141, 259 |
| abstract_inverted_index.amounting | 182, 238, 279 |
| abstract_inverted_index.currently | 274 |
| abstract_inverted_index.depending | 191 |
| abstract_inverted_index.determine | 38 |
| abstract_inverted_index.estimates | 255 |
| abstract_inverted_index.potential | 301 |
| abstract_inverted_index.pressure, | 202 |
| abstract_inverted_index.prevented | 126 |
| abstract_inverted_index.protocol, | 145 |
| abstract_inverted_index.published | 25, 254 |
| abstract_inverted_index.screening | 39, 144 |
| abstract_inverted_index.situation | 136 |
| abstract_inverted_index.treatment | 196 |
| abstract_inverted_index.Prevention | 11, 77, 218, 293 |
| abstract_inverted_index.Programme, | 265 |
| abstract_inverted_index.Programme. | 315 |
| abstract_inverted_index.prescribed | 207, 246 |
| abstract_inverted_index.prevented. | 46 |
| abstract_inverted_index.preventing | 303 |
| abstract_inverted_index.prevention | 16 |
| abstract_inverted_index.programmes | 36 |
| abstract_inverted_index.Conclusions | 290 |
| abstract_inverted_index.benefitting | 275 |
| abstract_inverted_index.combination | 90 |
| abstract_inverted_index.individuals | 165, 222 |
| abstract_inverted_index.methodology | 28 |
| abstract_inverted_index.performance | 40 |
| abstract_inverted_index.population. | 50 |
| abstract_inverted_index.programmes, | 103 |
| abstract_inverted_index.programmes. | 130 |
| abstract_inverted_index.Intervention | 51 |
| abstract_inverted_index.hypothetical | 134 |
| abstract_inverted_index.corresponding | 213 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 96 |
| corresponding_author_ids | https://openalex.org/A5048397189 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I165862685, https://openalex.org/I45129253 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8100000023841858 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.95136531 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |